Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steward

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Pilot study of oral anthocyanins for colorectal cancer chemopreventionSarah Thomasset, David P Berry, Hong Cai, et al.
Cancer Chemotherapy and Pharmacology|September 21, 2005
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastasesLucy Lee, Sunil Sharma, Bruno Morgan, et al.
Science Translational Medicine|October 4, 2013
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescenceKetan R Patel, Catherine Andreadi, Robert G Britton, et al.
British Journal of Cancer|July 17, 2003
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinomaK Dalhoff, J Dancey, L Astrup, et al.
Plos One|September 24, 2025
Exploring risk and protective factors which distinguish suicidal and self-harm behaviours from suicidal and self-harm ideation in young people: A systematic reviewMarianne E Etherson, Sieun Lee, Krystyna J Loney, et al.
Plos One|February 7, 2015
Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary noteMark I James, Lynne M Howells, Ankur Karmokar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequencesCarmen Hoh, David Boocock, Tim Marczylo, et al.
The Prostate|May 7, 2008
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolismFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and complianceRicky A Sharma, Stephanie A Euden, Sharon L Platton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentDavid J Boocock, Guy E S Faust, Ketan R Patel, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Pilot study of oral anthocyanins for colorectal cancer chemopreventionSarah Thomasset, David P Berry, Hong Cai, et al.
Cancer Chemotherapy and Pharmacology|September 21, 2005
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastasesLucy Lee, Sunil Sharma, Bruno Morgan, et al.
Science Translational Medicine|October 4, 2013
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescenceKetan R Patel, Catherine Andreadi, Robert G Britton, et al.
British Journal of Cancer|July 17, 2003
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinomaK Dalhoff, J Dancey, L Astrup, et al.
Plos One|September 24, 2025
Exploring risk and protective factors which distinguish suicidal and self-harm behaviours from suicidal and self-harm ideation in young people: A systematic reviewMarianne E Etherson, Sieun Lee, Krystyna J Loney, et al.
Plos One|February 7, 2015
Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary noteMark I James, Lynne M Howells, Ankur Karmokar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequencesCarmen Hoh, David Boocock, Tim Marczylo, et al.
The Prostate|May 7, 2008
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolismFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and complianceRicky A Sharma, Stephanie A Euden, Sharon L Platton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentDavid J Boocock, Guy E S Faust, Ketan R Patel, et al.
Pageof 26